The concept of comorbidity of dyscirculatory encephalopathy and vascular optical neuropathy (literature review)

The analysis of literature data on ischemic damage to the brain and the organ of vision was carried out in order to study etiological factors, pathogenetic processes, parallel flow and mutual influence of two nosological forms: dyscirculatory encephalopathy and vascular optic neuropathy. According to the World Health Organization, there is much more people suffering from cardiovascular diseases: atherosclerosis, hypertension, diabetes mellitus and coronary heart disease. These diseases result in ischemic damage to a number of vital organs, including the central nervous system and the visual analyzer. Chronic vascular pathology of both the brain and the eye is one of the leading causes of patients’ life quality decrease of and their disability. The “triggering” causes of brain and eye damage, according to researchers, are cerebral atherosclerosis, elevating/fluctuating blood pressure, coronary heart disease, and carbohydrate metabolism disorders. Disorders of the systemic blood supply caused by these etiological factors lead to a progressive lack of oxygen supply to organs and tissues, followed by the development of intracellular and cellular hypoxia, and an ischemic intracellular cascade of biochemical disorders leading to dysfunction and sometimes cell death.
In addition to direct hypoxic-ischemic damage of the nervous and visual systems cells, endothelial dysfunction contributes to the progression of these diseases, leading to a pronounced change in the wall at the level of small vessels, a change in its reactivity and a violation of the coagulation properties of blood, and as a consequence, to a gradual accumulation of ischemic and secondary degenerative changes in brain and eye cells.
Knowledge of etiological factors and patterns of development of brain and eye combined ischemic damage can allow clarifying the complex of diagnostic measures, developing preventive measures, as well as prescribe pathogenetically justified treatment of existing pathology.

1. Ministry of Health of the Russian Federation. Department of Monitoring, Analysis and Strategic Development of Healthcare of the Federal State Budgetary Institution “Central Research Institute of Organization and Informatization of Healthcare” of the Ministry of Health of the Russian Federation. The general morbidity of the adult population in Russia in 2017. Statistical materials. Part IV. Moscow; 2018. (In Russ.).

2. Shavlovskaya OA. Medical and social aspects of the elderly. Obshchestvo i zdorov’e: sovremennoe sostoyanie i tendentsii razvitiya: Materialy Vserossiyskoy nauchno-prakticheskoy konferentsii s mezhdunarodnym uchastiem. 2013; 2: 365-371. (In Russ.).

3. Skvortsova VI, Shetova IM, Kakorina EP, Kamkin EG, Boyko EL, Dashyan VG. Healthcare system for patients with stroke in Russia. Results of 10-years implementation of the measures aimed at improvement of medical care for patients with acute cerebrovascular events. Annals of Clinical and Experimental Neurology. 2018; 12(3): 5-12. (In Russ.). doi: 10.25692/ACEN.2018.3.1

4. Shakhparonova NV, Kadykov AS. Antioxidant therapy in cerebrovascular diseases. RMJ. 2010; 18(26): 1570-1572. (In Russ.).

5. Zhivolupov SA, Samartsev IN. Modern clinical analysis of cerebrovascular diseases: Key issues of differential diagnosis and pathogenetic treatment. Farmateka. 2012; 7(240): 87-94. (In Russ.).

6. Report on the implementation of the targets of the Irkutsk region state program “Development of healthcare” for 2019–2024. (In Russ.).

7. Levin OS, Chimagomedova ASh, Polyakova TA, Arablinsky AV. 60 years towards definition of dyscirculatory (vascular) encephalopathy: can we put new wine into old wineskins? Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018; 118(6-2): 13-26. (In Russ.). doi: 10.17116/jnevro201811806213

8. Vorobyeva OV. Chronic cerebral ischemia: From pathogenesis to therapy (recommendations to an outpatient neurologist). Russian Medical Inquiry. 2018; 2(5): 26-31. (In Russ.).

9. Zakharov VV, Gromova DO. Diagnostics and treatment of chronic cerebrovascular insufficiency. Effective Pharmacotherapy. 2015; 13: 48-54. (In Russ.).

10. Levin OS. Dyscirculatory encephalopathy: Anachronism or clinical reality? Sovremennaya terapiya v psikhiatrii i nevrologii. 2012; 3: 40-46. (In Russ.).

11. Akarachkova ES, Artemenko AR, Belyaev AA, Kadyrova LR, Kerimova KS, Kotova OV, et al. The brain as a target for stress and hypertension. Russian Medical Inquiry. 2019; 3(4-2): 59-64. (In Russ.).

12. Zakharov VV, Vakhnina NV, Gogoleva AG, Mezhmidinova SK. Diagnostics and treatment of chronic cerebral ischemia. Medical Council. 2020; 8: 36-45. (In Russ.). doi: 10.21518/2079-701X-2020-8-36-45

13. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9(7): 689-701. doi: 10.1016/S1474-4422(10)70104-6

14. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013; 61(6): 1354-1359. doi: 10.1161/HYPERTENSIONAHA.111.00430

15. Meissner A. Hypertension and the brain: A risk factor for more than heart disease. Cerebrovasc Dis. 2016; 42(3-4): 255-262. doi: 10.1159/000446082

16. Dadasheva MN, Podrezova LA, Shuchalin OG, Vishnyakova TI, Rashidova ESh, Smirnova LA, et al. Algorithm of therapy of dyscirculatory encephalopathy in patients with arterial hypertension in general medical practice. RMJ. 2009; 17(20): 1320-1324. (In Russ.).

17. Rachin AP, Vygovskaya SN, Nuvakhova MB, Doroginina AYu. Chronic cerebral ischemia – from correct diagnosis to adequate therapy. RMJ. 2015; 23(12): 694-698. (In Russ.).

18. Putilina MV. Cognitive disorders in cerebrovascular pathology. Moscow: MIA-Print; 2011. (In Russ.).

19. Vertkin AL, Silina EG. Chronic cerebral ischemia. Guide for practitioners. Мoscow: Eksmo; 2020. (In Russ.).

20. Gusev EI, Skvortsova VI, Stakhovskaia LV. Epidemiology of stroke in Russia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2003; 8: 4-9. (In Russ.).

21. Tuzlaev VV, Egorov VV, Kravchenko IZ, Smoliakova GP. Clinical features of ocular ischemic syndrome in atherosclerotic lesions of the internal carotid artery. Practical Medicine. 2018; 16(5): 173-178. (In Russ.).

22. Zavgorodnaya TS, Sarzhevskaya LE, Bezdenezhnaya OA, Bezuglaya EA. Ocular ischemic syndrome. Modern principles of diagnosis and treatment. Zaporozhye; 2012. (In Russ.).

23. Frolov MA, Alkam KM. Manifestations of ocular ischemic syndrome in patients with atherosclerotic stenosis of extracranial carotid arteries. Bulletin of Pirogov National Medical & Surgical Center. 2013; 8(4): 25-28. (In Russ.).

24. Pliukhova AA, Balatskaia NV, Budzinskaia MV. Ocular changes in systemic atherosclerosis. Vestnik oftalmologii. 2013; 129(1): 71-74. (In Russ.).

25. Ponomareva MN. Diagnostics and drug correction of hemodynamic disorders in ischemic optic neuropathy in patients with cardiovascular diseases: Dissertation Abstract of Cand. Sc. (Med.). Moscow; 2010. (In Russ.).

26. Frolov MA, Sakhovskaya NA, Frolov AM, Pryamikov AD. Feature of ocular-ischemic syndrome in patients with cardiovascular pathology. Literature review. Ophthalmology in Russia. 2020; 17(2): 188-194. (In Russ.). doi: 10.18008/1816-5095-2020-2-188-194

27. Kiseleva TN, Tarasova LN, Fokin AA, Bogdanov AG. Blood flows in ocular vessels in two patterns of ocular ischemic syndrome. Vestnik oftalmologii. 2001; 117(1): 22-24. (In Russ.).

28. Ponomareva MN, Klyashev SM, Konovalova NA, Sklyar LV, Sazonov NN, Elmer LI. Atherosclerotic vascular lesion of the carotid basin is a factor of ischemic neuropathy in persons of gerontological age. Materialy V Evro-aziatskoy konferentsii po oftal’mokhirurgii. Ekaterinburg; 2009: 322. (In Russ.).

29. Makhkamova DК. Etiopathogenesis of ocular ischemic syndrome. Vestnik oftalmologii. 2017; 133(2): 120-124. (In Russ.). doi: 10.17116/oftalma20171332120-124

30. Makkaeva SM, Yuzhakova OI, Ramazanova LSh, Aligadzhieva LG. New aspects of the pathogenesis of ocular ischemic syndrome. URL: http://www.eyenews.ru/news/item108118 [date of access: 24.05.2022]. (In Russ.).

31. Hazin R, Daoud YJ, Khan F. Ocular ischemic syndrome: Recent trends in medical management. Curr Opin Ophthalmol. 2009; 20(6): 430-433. doi: 10.1097/ICU.0b013e3283313d38

32. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome – a systematic review. Med Sci Monit. 2012; 18(8): RA138-RA144. doi: 10.12659/msm.883260

33. Katsnelson LA, Forofonova TI, Bunin AYa. Vascular eye diseases. Moscow: Medicine; 1990. (In Russ.).

34. Fedin AI. Diagnosis and treatment of chronic cerebral ischemia. Consilium Medicum. 2016; 18(2): 8-12. (In Russ.). doi: 10.26442/2075-1753_2016.2.8-12

35. Mendelevich EG. Chronic cerebral vascular insufficiency: Clinical and neuroimaging parameters, risk factors and neuroprotective therapy. RMJ. 2016; 24(7): 424-428. (In Russ.).

36. Levin OS. Approaches to the diagnosis and treatment of cognitive disorders in dyscirculatory encephalopathy. Difficult Patient. 2008; 11(6): 14-20. (In Russ.).

37. Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc. 1959; 169(12): 1286-1296. doi: 10.1001/jama.1959.03000290012005

38. Pugin MN. Nervous diseases. Moscow: Meditsina; 2002. (In Russ.).

39. Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts. Int J Stroke. 2016; 11(1): 6-18. doi: 10.1177/1747493015607485

40. Dushin NV, Radysh BB, Gonchar PA, Kootenev AV. Visual disorders as manifestations of transient ischemic attacks in the vertebral-basilar basin. Vestnik oftalmologii. 2001; 117(2): 27-29. (In Russ.).

41. Marshall RS. Effects of altered cerebral hemodynamics on cognitive function. J Alzheimers Dis. 2012; 32(3): 633-642. doi: 10.3233/JAD-2012-120949

42. Laurent S, Katsahian S, Fassot C, Tropeano A-I, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003; 34(5): 1203-1206. doi: 10.1161/01.STR.0000065428.03209.64

43. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res. 2007; 30(4): 335-340. doi: 10.1291/hypres.30.335

44. Nazarova ОА, Nazarova АV. Vascular lesion in arterial hypertension. Bulletin of the Ivanovo Medical Academy. 2012; 17(2): 60-66. (In Russ.).

45. Solovieva EYu, Farrahova KI, Karneev AN, Chipova DT. Phospholipids metabolism disorders in acute stroke. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2016; 116(1): 104-112. (In Russ.). doi: 10.17116/jnevro201611611104-112

46. Egorov VV, Smoliakova GP, Danilova LP. Clinico-pharmacological aspects of neuropatronage of ischemic-hypoxic lesions of the visual nervous system. Zdravookhranenie Dal’nego Vostoka. 2014; 4(62): 37-42. (In Russ.).

47. Levin OS. Combined pharmacotherapy of dyscirculatory encephalopathy. Farmateka. 2015; 9: 1-6. (In Russ.).

48. Kuznetsov VI, Morrison VV, Lisko OB, Tsareva TD, Sretenskaya DA, Gavrilova IB, et al. Lipids in the structure and functions of biological membranes (Review). Saratov Journal of Medical Scientific Research. 2014; 10(2): 262-266. (In Russ.).

49. Shumakher GI, Vorobiyova YeN, Nechounayeva YeV, Khoreva MA, Vorobiyov RI, Simonova OG, et al. Role of endothelium dysfunction in starting immunopathologic response in chronic brain ischemia. Bulletin of Siberian Medicine. 2008; 5: 214-219. (In Russ.).

50. Afanasiev VV. Clinical application of citicolinum and its role in homeostasis of neurons cellular membranes and effector organs. Emergency Medicine. 2016; 1(72): 46-50. (In Russ.).

51. Polyakov IA, Malozemov IV, Stepanova NS. Antioxidant therapy in the complex treatment of dyscirculatory encephalopathy. Terra Medica Nova. 2009; 4-5: 22-24. (In Russ.).

52. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging. Lancet Neurol. 2013; 12(5): 483-497. doi: 10.1016/S1474-4422(13)70060-7

53. Lipovetsky BM. Clinical lipidology; 2nd ed. Textbook for academic baccalaureate. Moscow: Yurayt; 2019. (In Russ.).

54. Vladimirov YuA. Biological membranes and non-programmed cell death. Sorosovskiy obrazovatel’nyy zhurnal. 2000; 6(9): 2-9. (In Russ.).

55. Zinchuk VV, Glebov AN. NO-dependent mechanisms of blood oxygen-binding properties formation in oxidative stress. Journal of the Grodno State Medical University. 2007; 1(17): 139-142. (In Russ.).

56. Evstratova OR, Kharitonova AS, Luschik MV. The role of free radical oxidation processes in the development of pathologies. International Student Research Bulletin. 2016; 4-2: 146-147. (In Russ.).

57. Dorofienko NN. The role of vascular endothelium in the organism and the universal mechanisms of changing its activity (review). Bulletin Physiology and Pathology of Respiration. 2018; 68: 107-116. (In Russ.). doi: 10.12737/article_5b1a0351210298.18315210

58. Petukhov VA. Endothelial dysfunction: the current state of the issue (based on the materials of the scientific symposium). Consilium Medicum. Surgery. (Supplement). 2008; 1: 3-11. (In Russ.).

59. Shabrov AV, Apresyan AG, Dobkes AL, Ermolov SU, Ermolova TV, Manasyan SG, et al. Current methods of endothelial dysfunction assessment and their possible use in the practical medicine. Rational Pharmacotherapy in Cardiology. 2016; 12(6): 733-742. (In Russ.). doi: 10.20996/1819-6446-2016-12-6-733-742

60. Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: A clinical review. Neurology. 2019; 92(24): 1146-1156. doi: 10.1212/WNL.0000000000007654

61. Lei Ch, Deng Q, Li H, Zhong L. Association between silent brain infarcts and cognitive function: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2019; 28(9): 2376-2387. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.036

62. Zakharov VV, Sleptsova KB, Martynova OO. Chronic cerebral ischemia: A view from the XXI century. RMJ. 2021; 29(5): 45-49. (In Russ.).

63. Smetneva NS, Goloborodova IV, Popkova AM, Samoilova NV, Igonina NP, Shatrova GV, et al. Therapy of cognitive disorders in chronic cerebral ischemia in general medical practice. RMJ. 2018; 26(7): 15-22. (In Russ.).

64. Kutimova VG, Sukhorukova AV. Clinical analysis of patients with anterior ischemic neuropathy. Tambov University Review. Series: Natural and Technical Sciences. 2012; 17(1): 253-255. (In Russ.).

65. Latypova EA. Effectiveness of nicotinic acid and pentoxifylline in a complex treatment of optic nerve diseases. Bashkortostan Medical Journal. 2016; 11(1): 33-37. (In Russ.).

66. Shershevskaya SF, Levina FG, Eremenko AI, et al. Clinical forms of optical vascular neuropathies in elderly and senile persons. Oftal’mologicheskiy zhurnal. 1981; 1: 23-25. (In Russ.).

67. Eremenko AI. The main forms of vascular optical neuropathies: Dissertation Abstract of Doct. Sc. (Med.). Odessa; 1991. (In Russ.).

68. Brovkina AF, Schuko AG. On differentiated diagnostics of some types of optical neuropathy. Russian Journal of Clinical Ophthalmology. 2008; 1: 30-33. (In Russ.).

69. Svirin AV, Eliseeva TO, Hou Xianzhu, et al. Improving the effectiveness of treatment of acute ischemic diseases of the optic nerve and retina. VII Sjezd oftal’mologov Rossii: Tezisy dokladov. Moscow; 2000: 174-175. (In Russ.).

70. Amansakhatov ShA, Shchelkunov AV. Effectiveness of treatment of anterior ischemic neuropathy. VII Sjezd oftal’mologov Rossii: Tezisy dokladov. Moscow; 2000: 171. (In Russ.).

71. Ryzhaeva OV, Krikun TI, Grishina EE, et al. On the issue of tactics of treatment of ischemic eye lesions. VII Sjezd oftal’mologov Rossii: Tezisy dokladov. Moscow; 2000: 327. (In Russ.).

72. Makkaeva SM, Puzin MN, Ramazanova LS. Clinical features of ocular ischemic syndrome. Klinicheskaya nevrologiya. 2009; 2: 14-18. (In Russ.).

73. Kamilov KhM, Kasimova MS, Makhkamova DK. State of general and regional hemodynamics at ocular ischemic syndrome. Tambov University Review. Series: Natural and Technical Sciences. 2015; 20(3): 596-599. (In Russ.).

74. Kamilov KhM, Kasimova MS, Makhkamova DK. Neurobiochemical criteria for the diagnostics of ocular ischemic syndrome. National Journal Glaucoma. 2016; 15(1): 46-51. (In Russ.).

75. Pyankov VZ. Mechanisms of violation of regional hemodynamics and microcirculation of the eye in arterial hypertension. VII Sjezd oftal’mologov Rossii: Tezisy dokladov. Moscow; 2000: 288. (In Russ.).

76. Sheremet NL, Smirnova TB, Ronzina IA, Khanakova NA, Meshkov AD, Kozlovskaya NL, et al. Analysis of structure, causes, and risk factors of ischemic optic neuropathy. Vestnik oftalmologii. 2017; 133(6): 50-58. (In Russ.).

77. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009; 28(1): 34-62. doi: 10.1016/j.preteyeres.2008.11.002

78. Arenillas JF. Intracranial atherosclerosis current concepts. Stroke. 2011; 42(1 Suppl): S20-S23. doi: 10.1161/STROKEAHA.110.597278

79. Кaiotkina ЕV, Chistyakova SV, Кuvyrkova OI, Ivanova NV. The results of complex treatment of ocular ischemic syndrome. Vestnik of the Orenburg State University. 2015; 12(187): 100-103. (In Russ.).

80. Arustamova AA, Pokrovsky MV, Shabelnikova AS, Kashuba AS, Yakushev VI. Pharmacological preconditioning of ischemic damage of the retina. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Meditsina. Farmatsiya. 2012; 22(141): 13-19. (In Russ.).